Biotech Patent Held Invalid For Failing to Disclose Preferred Host Cells

Contributor: Foley Hoag LLP

SUMMARY: On March 8, 2010, the Federal Circuit affirmed a ruling of the International Trade Commission invalidating the asserted claims of two U.S. patents for failure to meet the best mode requirement. Ajinomoto Co., Inc. v. ITC, available here. Foley Hoag represented the prevailing party, Global Bio-Chem Technology Group Company Limited (GBT), a Chinese biotechnology company. The patents covered the production of lysine using genetically modified bacteria.

Please see full alert below for more information.

Download: Word (.doc) [23KB] | PDF [170KB]

Email This Report Problem

Share |

LOADING PDF: If there are any problems, click here to download the file.

DOCUMENT INFO

Doc Type:
Legal Article/Newsletter

Published: 3/11/2010
See Related Docs

Legal Article/Newsletter Name:
Biotech Patent Held Invalid For Failing to Disclose Preferred Host Cells

Legal System: United States

Subject Matter:
International Law & Trade
Science, Computers, & Technology
Antitrust & Trade Regulation
Intellectual Property